While all medications carry some risk of side effects, GLP-1s tend to have a favorable side effect profile, especially when compared to other weight-loss medications
So far, in the long run, obesity prevention and treatment strategies-whether at the individual or group level, have not been very successful (8)
Use, Access and Affordability of GLP-1 Drugs KFFs latest Health Tracking Poll provides an update to last years poll measuring public use of GLP-1 agonists, a group of prescription drugs including name brands like Ozempic, Wegovy, Zepbound and others commonly prescribed for weight loss, the treatment of diabetes, reduction of cardiovascular disease risk, and some other chronic conditions 1
Ipamorelins role in glucocorticoid-induced bone loss
"Obesity is not like an infection where you take antibiotics and you're done," says Rubino, sighing
Common side effects include nausea and vomiting (slightly more common with the pill version), diarrhoea and/or constipation and abdominal discomfort, but these generally settle once people get used to the medicine